We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Articles

Article

The Hunt for a Pan-Coronavirus Vaccine

Coronaviruses patently cause destructive pandemics, and it is possible that we will experience another one in our lifetimes. It makes sense to prepare a vaccine for possible future outbreaks, or for new variants of SARS-CoV-2, writes Anthony King.

Article

The Pursuit of Global, Sustainable and Cooperative Open Science

Technology Networks had the pleasure of speaking with Nobel Laureate Elizabeth Blackburn on her impressive contributions to science and society. She highlights early inspirations that cemented her love of science, elaborates on the research that led to her being co-awarded the 2009 Nobel Prize in Physiology or Medicine, and explains why she is advocating for sustainable, cooperative and open science.
Article

Closing the Vaccine Gap

Here, we explore some of the reasons behind vaccine hesitancy and highlight potential ways to combat the issue.
Article

COVID-19 Childhood Vaccines: Why Don’t They Last a Lifetime, Like the Measles Shot?

Sophie Prosolek explores why some vaccines last a lifetime, while others do not, for Technology Networks.
Article

Designing Vaccines With Reverse Vaccinology

Most vaccine development begins with looking at the pathogen. Scientists pinpoint key residues needed for the virus to enter the body and develop vaccines that train the body to recognize signatures of the foreign invader. Kevin O'Neil Saunders, associate professor of surgery and director of research at the Duke Human Vaccine Institute at Duke University develops vaccines after analyzing the body’s immune response to a pathogen.
Article

The Omicron Variant Highlights the Need for Smarter, Future-Proof Vaccine Design

Investment in vaccine science and technology development can provide us with the tools to respond to pathogens with pandemic potential. In this opinion article, Ariana Gomes discusses the use of AI for creating universal vaccines.
Article

Vaccines: Just Add Water

Cold-chain distribution requirements complicate vaccine access, reducing vaccination rates for life-threatening, but preventable diseases. Now, researchers have developed a portable production platform for shelf-stable, antibacterial vaccines.
Article

A Next-Generation SARS-CoV-2 Vaccine

A naturally occurring nanoparticle yields a new type of vaccine that offers broad-acting protection against emerging SARS-CoV-2 variants. With further development, the approach may lead to a pan-coronavirus vaccine.
Article

Progress Towards a Mucosal Vaccine for Pneumonia

In a new study, researchers describe a subunit mucosal vaccine that induces broadly protective immunity against Klebsiella pneumoniae strains. Technology Networks interviewed author Jay Kolls to learn more about the findings and their significance.
Article

Nanoparticles – Enabling Innovation in Vaccine Design

Nanoparticle-based vaccines have emerged as a potential alternative to conventional and subunit vaccines. This article explores the various properties and advantages of nanoparticles which allow the design of vaccines with enhanced antigen presentation and strong immunogenicity.
Advertisement